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General features
The human gut microbiota represents an extraordinary
complex microbial consortium whose activities are
believed to be crucial for human health and well-being.
The formation of the human gut microbiota commences at
the point of delivery of an essentially sterile baby and then
further develops in terms of diversity and complexity dur-
ing weaning, adolescence and into adult life. The microbial
groups identified in the gut microbiota encompass repre-
sentatives of all three domains of life, i.e. Archaea, Bacte-
ria and Eukarya, whose dynamics are manoeuvred by
various forces, such as viruses, which are believed to act
as powerful drivers of gut microbiota homoeostasis (for a
review see Ref.: Milani et al., 2017). The human gut micro-
biota is composed of autochthonous members that are
believed to establish stable interactions with their host, as
well as a transient microbial consortium whose members
are mainly acquired through oral intake and who are not
presumed to colonize the gut in the presence of a
homoeostatic microbiota. The diverse components of the
gut microbiota are known to elicit key effects in the
maintenance and promotion of human health by (i) sup-
porting the transformation of food components so as to
release nutrients that would otherwise not be accessible to
the host, (ii) stimulating host cell differentiation, (iii) defend-
ing the body against pathogen invasion and (iv) exerting
immune modulatory activities. Several epidemiological
studies have clearly demonstrated a correlation between
factors disrupting the gut microbiota during childhood and
the occurrence of certain immune and metabolic disorders
at later stages of life (Eggesbo et al., 2003; Huh et al.,
2012; Sevelsted et al., 2015), backed up by other scientific
data that link long-term health benefits to the infant gut
microbiota (Relman, 2012). This scientific realization has
in turn opened up the search for strategies that aim to
influence the origin, development, maturation and activities
of the infant microbiota by a plethora of nutraceutical/func-
tional food products including probiotics and prebiotics.
An interesting feature of the human gut microbiota is
that the development of such a microbial assemblage
reaches homoeostasis, which is characterized by a com-
positional equilibrium of its microbial members (Tamboli
et al., 2004). Various events may cause disturbances in
this so-called microbiota climax, thereby causing a state
that has been referred to as dysbiosis. The concept of
dysbiosis is controversial, simply because there is still a
lack of knowledge and understanding of what precisely
represents a ‘normal’ or healthy microbiota. Dysbiosis is
usually associated with harmful effects and may have
long-term consequences leading to disorders or dis-
eases, including obesity, diabetes and inflammatory
bowel disease (IBD). However, one should realize that
significant variations occur in gut microbiota composition
during host development from infancy to early childhood,
from young to ageing adults and during pregnancy. Even
if such modifications appear to be similar to those
described in certain disease conditions, in their evolving
context they do not necessarily lead to illness but,
rather, may enhance fitness and survival and thus are
considered to be beneficial (Nuriel-Ohayon et al., 2016).
The origin of the human gut microbiota
The establishment of the infant gut microbiota is the
result of a complex process that is influenced by many
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environmental and host factors (Rodriguez et al., 2015)
(Fig. 1). Notably, although the dogma of a sterile in utero
environment, which claims that microbial colonization
only commences upon birth, is still generally accepted,
there is growing evidence indicating that very early colo-
nization of humans may occur at the fetal stage (Jime-
nez et al., 2005; DiGiulio et al., 2008; Aagaard et al.,
2014). The route by which bacteria achieve this prebirth
colonization is still obscure. However, the recent discov-
ery of a circulating microbiota that is present in human
blood (Kowarsky et al., 2017) is not only reinforcing the
notion that there is not any human organ that is com-
pletely sterile, but also lending further support to the
hypothesis of a prenatal establishment of the gut micro-
biota. This perception may facilitate new research ave-
nues and possible manipulation of the human gut
microbiota through probiotic intervention during preg-
nancy.
The progress and evolution of the gut microbiota is a
dynamic and non-casual process, involving intricate
interactions between key microbial components (Aver-
shina et al., 2013, 2016). This process is affected by
several perinatal conditions, such as mode of delivery,
type of feeding and antibiotic usage (Milani et al., 2017).
In addition, diet, mother’s age and metabolic status, fam-
ily genetics and lifestyle have been described to influ-
ence the infant gut microbiota composition (Milani et al.,
2017).
The origin of the human gut microbiota is associated
with the inheritance of an assemblage of microorganisms
that are vertically transmitted from mother to her off-
spring. Remarkably, the mammalian newborn does not
appear to passively acquire a new microbiota, but the
mother seems to actively promote the transfer of specific
members of her microbiota to her offspring and may thus
directly influence the development of the new microbiota
of her child. This selective vertical transmission of
microbes is driven by the specific nourishment with pre-
biotic milk compounds favouring certain microorganisms,
in particular bifidobacteria. Recently, metagenomic inves-
tigations of mothers and corresponding newborns have
highlighted the existence of shared bifidobacterial com-
munities, in particular bifidobacterial strains that are cap-
able of metabolizing specific glycans contained in
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Fig. 1. Development of the human gut throughout the entire life. The diagram describes a list of prenatal, neonatal and postnatal influences that
may contribute to the establishment/maturation/succession of bacterial consortia in the human gut.
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human milk, i.e. human milk oligosaccharides (HMOs;
Milani et al., 2015; Duranti et al., 2017). This vertical
transmission route involving bifidobacterial strains
includes human milk as a vectoring system (Milani et al.,
2015; Duranti et al., 2017). A similar scenario seems to
occur in other non-human primates as well as in non-pri-
mate mammals, where bifidobacterial strains were found
to be maternally inherited by means of mother’s milk
(Milani et al., 2017). These findings support the hypothe-
sis that those bifidobacteria that are directly acquired
from mothers are maintained in the adult gut, perhaps at
very low levels, in order to be ultimately transferred to
the next generation (Milani et al., 2015). This intriguing
process may therefore reflect millennia of co-evolution
between bifidobacteria and their mammalian host.
As mentioned above, human milk represents an
important selective medium for the establishment and
modulation of the gut microbiota during the early stages
of life. In fact, human milk, apart from representing a
source of nutrients for the infant, encompasses a large
amount of carbohydrates such as HMOs; i.e., 1 l of
human milk contains 5–20 g of these complex glycans,
which is typically more than all human milk proteins
combined and which acts as a highly selective nourish-
ment for specific members of the infant gut microbiota.
Notably, HMOs encompass a diverse group of complex
glycans, where five monosaccharide building blocks
glucose, galactose, N-acetylglucosamine, fucose and
N-acetyl-neuraminic acid are arranged in a variety of
combinations, which generates more than 200 struc-
turally distinct HMOs (Bode, 2012; Milani et al., 2017).
Furthermore, it should be noted that HMO content and
composition depend on lactation stage, the genetics of
the mother and environmental factors (McGuire et al.,
2017). Therefore, human milk can be considered as a
‘personalized, mother-specific nutrition’ and HMOs as
‘personalized prebiotics’, together promoting the arrange-
ment of a distinct infant gut microbiome, the composition
of which being determined, at least in part, by the HMOs
present in mother’s milk. Every mother provides a differ-
ent HMO mix to her infant(s), determining distinct infant
microbial assemblies with potential short- and long-term
effects (Milani et al., 2017).
Only a small number of bacteria, such as the Bifi-
dobacterium longum subsp. infantis ATCC 15697 and
Bifidobacterium bifidum PRL2010, have been shown to
possess the enzymatic machinery to metabolize many if
not all HMOs present in human milk (Sela et al., 2008;
Turroni et al., 2010). In contrast, other bacteria can
access and metabolize only specific elements of the
HMO mixture. Nevertheless, microbial communities may
be capable to act in concert, consecutively breakdown
and metabolize HMO structures in a team effort through
cross-feeding activities (Egan et al., 2014a,b; Gotoh
et al., 2018).
The early microbiota as a key determinant of human
health
In the course of the initial microbial colonization, the
gut microbiota is still unstable and is going through
continuous modifications until the infant is 2–3 years
old, at which stage the microbiota reaches a composi-
tion resembling that of an adult (Yatsunenko et al.,
2012). Despite this apparent instability of the infant gut
microbiota, it is very well known that microbiota–host
communications are particularly important during these
early stages of life. In fact, during this period, micro-
biota–host interactions represent key events underpin-
ning immune development of the human host, with
consequent creation and conservation of the
homoeostasis of the host microbiota during infancy.
Remarkably, these actions have not only immediate
health effects but also long-term health consequences.
In this context, the infant gut microbiota provides a
strong antigenic stimulus needed for the maturation of
the gut and associated immune functions (Sommer and
Backhed, 2013; Gensollen et al., 2016). This effect also
impacts on the development of the distal organs, by
influencing the host at systemic level (Clarke et al.,
2014; Neuman et al., 2015). Consequently, it is
accepted that the foundation of human health is linked
with the establishment and development of the micro-
biota (Arrieta et al., 2014; Nylund et al., 2014). In this
context, it has been shown that faecal levels of IgA,
which is considered to be an important marker linked to
the risk of disease, may be associated with the pres-
ence of specific microbiota members (Moon et al.,
2015). Thus, it may be argued that any modification
from the normal neonatal microbial colonization process
represents a risk factor for disease later in life. Cer-
tainly, accumulating scientific evidence indicates that
gut microbiota alterations during the first stages of life
are predictors of disease development (Kalliomaki
et al., 2008; Fujimura et al., 2016; Simonyte Sjodin
et al., 2016). In this context, it should also be noted
that the early microbiota is connected to infant malnutri-
tion and associated growth impairment (Arboleya et al.,
2012; Gough et al., 2015; Reyes et al., 2015; Charbon-
neau et al., 2016).
There is a long list of studies involving immune
pathologies such as atopic eczema and asthma, IBD,
irritable bowel syndrome (IBS), type 1 diabetes (T1D),
metabolic disorders, like obesity type 2 diabetes, display-
ing a clear correlation with alteration in the early gut
microbiota.
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The infant gut microbiota and its impact on the host
health
An incorrect establishment of the gut microbiota during
the early stages of life has been shown to be associated
to disruption of immune homoeostasis, ultimately impact-
ing on the risk of allergic diseases later in life (Johnson
and Ownby, 2016). Interestingly, microbiota differences
related to low loads of certain bacterial taxa such as bifi-
dobacteria and other intestinal anaerobes such as Fae-
calibacterium prausnitzii and Coprococcus eutactus were
identified in infants that later developed atopy or asthma
(Fujimura et al., 2016). Even if these results do not con-
nect an early microbiota profile with a decrease of atopic
eczema disorder, they do indirectly highlight the protec-
tive role of a butyrate-producing microbiota against the
development of atopic eczema. In fact, it has been
shown that a low relative abundance of butyrate produc-
ers is a risk predictor for the development of atopic
eczema (Simonyte Sjodin et al., 2016).
Several studies have reported a clear association
between early live antibiotic exposure and childhood
obesity (Cox and Blaser, 2015). These findings indicate
that antibiotics-mediated disturbances of the gut micro-
biota, either during prenatal or postnatal periods,
enhance the risk of obesity (Turta and Rautava, 2016).
Recently, it has been proposed that early microbial pro-
files may predict overweight in children. In this context, it
has been shown that the bifidobacterial loads at 6 and
12 months inversely correlate with overweight in children
(Kalliomaki et al., 2008).
It has been proposed that microbiota alterations during
early infancy cause a pro-inflammatory environment that
facilitates the occurrence of autoimmune disease such
as T1D (Kostic et al., 2015). In particular, such micro-
biota perturbations include a lower diversity and signifi-
cant differences in the ratio of the most abundant
intestinal phyla, i.e. Firmicutes and Bacteroidetes, as
well as a reduced load of the butyrate producer
F. prausnitzii (Gulden et al., 2015). Notably, butyrate-
producing species have been suggested to exert a pro-
tective role in reducing the risk of developing T1D (de
Goffau et al., 2014).
Several severe diseases involving intestinal inflamma-
tory symptoms have been linked to deviations of the
early life gut microbiota. The concept that the human gut
immune system is educated by the early microbial colo-
nization assumes a connection between pioneering
microbial inhabitants of the human intestine and subse-
quent gut inflammatory disease/disorder, such as IBD
and IBS. Interestingly, a number of clinical trials have
indicated that early changes in the population of specific
microbial groups herald the onset of intestinal inflamma-
tory diseases at later stages of life (O’Mahony et al.,
2009, 2014; Schirbel and Fiocchi, 2011; Wang et al.,
2016). Nevertheless, conclusive data about the long-last-
ing effects of dysbiosis in the early life and the develop-
ment of IBD and IBS in later stages of life are rare and
do not allow the establishment of causality.
Conclusions
We are only beginning to unveil early life interactions
between microbes and their mammalian host, and, if
disturbed, the resulting long-lasting effects on human
health. Consequently, it may be time to develop alter-
native strategies to facilitate the appropriate establish-
ment of the infant gut microbiota in those situations in
which this process is prevented, challenged or dis-
rupted.
This perception has fuelled the development of func-
tional food strategies involving various nutraceutical
products such as probiotics and/or prebiotics capable of
modulating the infant gut microbiota establishment/matu-
ration. However, such intervention approaches require
thorough assessment of the composition of the human
early gut microbiota and the identification of key micro-
biota components that play a role in the aetiology of dis-
eases and that can thus act as microbial biomarkers.
The identification of microbial biomarkers therefore rep-
resents an important activity for future prophylactic
approaches as well as for early diagnosis of diseases.
We are only starting to understand the importance of
microbiota composition during pregnancy in terms of a
reservoir of bacteria for the establishment of gut micro-
biota in newborns. However, there are many open ques-
tions about how certain bacteria are specifically
transferred by the mother to their children. Furthermore,
we still do not know whether bacteria may transfer from
mother to child through a systemic route, e.g. through
dendritic cells, blood or milk. The answers to all these
questions combined with the possibility of prenatal bac-
terial colonization may revolutionize paediatrics in the
coming years.
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